• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates].

作者信息

Hasegawa M, Saika T, Matsuzaki K, Kobayashi I, Fujioka T, Nasu M, Saionji K, Igari J

机构信息

Chemotherapy Division, Mitsubishi Kagaku Bio Clinical Laboratories.

出版信息

Kansenshogaku Zasshi. 1998 Mar;72(3):207-10. doi: 10.11150/kansenshogakuzasshi1970.72.207.

DOI:10.11150/kansenshogakuzasshi1970.72.207
PMID:9585692
Abstract

Agar dilution and semi-solid agar dilution were used to determine the MIC of faropenem (FRPM) against 24 H. pylori isolates. FRPM was active against clarithromycin resistance H. pylori isolates. And, the MICs obtained by both methods were in agreement. The results suggest that FRPM was not affected by pH and is a clinically useful oral antibiotic for the eradication therapy of H. pylori infections.

摘要

相似文献

1
[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates].
Kansenshogaku Zasshi. 1998 Mar;72(3):207-10. doi: 10.11150/kansenshogakuzasshi1970.72.207.
2
Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates.采用风干微孔板的微量肉汤稀释法测定幽门螺杆菌分离株对克拉霉素和阿莫西林的最低抑菌浓度。
J Med Microbiol. 2004 May;53(Pt 5):403-406. doi: 10.1099/jmm.0.05397-0.
3
Efficacy and safety of faropenem in eradication therapy of Helicobacter pylori.法罗培南在幽门螺杆菌根除治疗中的疗效与安全性。
Helicobacter. 2007 Dec;12(6):618-22. doi: 10.1111/j.1523-5378.2007.00551.x.
4
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].新型口服青霉烯类抗生素法罗培南对肠出血性大肠杆菌O157菌株的体外抗菌活性
Jpn J Antibiot. 1999 Aug;52(8):541-53.
5
Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.雷贝拉唑、阿莫西林和法罗培南三联疗法作为初次幽门螺杆菌根除治疗失败后的二线治疗的疗效。
Hepatogastroenterology. 2005 Mar-Apr;52(62):645-8.
6
A new semi-solid agar dilution method for determining amoxycillin, clarithromycin and azithromycin MICs for Helicobacter pylori isolates.
J Antimicrob Chemother. 1997 Nov;40(5):713-6. doi: 10.1093/jac/40.5.713.
7
In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.幽门螺杆菌对氨苄西林、克拉霉素、甲硝唑和奥美拉唑的体外敏感性
J Antimicrob Chemother. 1997 Dec;40(6):881-3. doi: 10.1093/jac/40.6.881.
8
[Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children].[儿童幽门螺杆菌对克拉霉素耐药的患病率及机制]
Zhonghua Er Ke Za Zhi. 2004 Nov;42(11):850-3.
9
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.台湾幽门螺杆菌分离株的体外比较抗菌药敏试验和抗菌联合用药的协同活性。
J Microbiol Immunol Infect. 2015 Feb;48(1):72-9. doi: 10.1016/j.jmii.2012.08.021. Epub 2012 Oct 1.
10
The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia.安纳托利亚东南部地区原发性和继发性幽门螺杆菌对克拉霉素耐药的流行情况及可能的相关辅助因素：数据报告
Hepatogastroenterology. 2008 Jan-Feb;55(81):289-93.